Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02265281

Ligand	Ligand name	Chain	PDB	Tanimoto
FOL	FOLIC ACID	A	1PJ6	0.71
FOL	FOLIC ACID	A,B	1RD7	0.71
FOL	FOLIC ACID	A,B	1DHF	0.71
FOL	FOLIC ACID	A,B,C,D,E	1QZF	0.71
FOL	FOLIC ACID	A	4CD2	0.71
FOL	FOLIC ACID	A	1RX7	0.71
FOL	FOLIC ACID	A	1RX2	0.71
FOL	FOLIC ACID	A	1RX8	0.71
FOL	FOLIC ACID	A	1RA2	0.71
FOL	FOLIC ACID	A,B	1RE7	0.71
FOL	FOLIC ACID	A	7DFR	0.71
FOL	FOLIC ACID	A	1VIF	0.71
FOL	FOLIC ACID	A,B	1RB2	0.71
FOL	FOLIC ACID	A	1CD2	0.71
FOL	FOLIC ACID	A	2CD2	0.71
FOL	FOLIC ACID	A,B	1DYI	0.71
FOL	FOLIC ACID	A	1DRF	0.71
FOL	FOLIC ACID	A,B,C,D	3BMC	0.71
FOL	FOLIC ACID	A,B	2D0K	0.71
FOL	FOLIC ACID	A	1RA8	0.71
CY0	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	A	2J5E	0.71
OQB	4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID	A	1RWW	0.72
CM9	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	A	2W09	0.76
CII	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	A	2W0A	0.71
CDO	2-((R)-1-((S)-2-(N-(6-CARBAMIMIDOYLPYRIDIN-3-YL)METHYLCARBAMOYL)-2H-PYRROL-1(5H)-YL)-3-CYCLOHEXYL-1-OXOPROPAN-2-YLAMINO)ACETIC ACID	H	2ANM	0.72
NPH	CYSTEINE-METHYLENE-CARBAMOYL-1,10-PHENANTHROLINE	A	1A18	0.81
I11	[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE	H	1UVS	0.71
34Q	(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine	A	2RIP	0.81
BTH	4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-PENTANOIC ACID	A	1RWO	0.72
QUI	2-CARBOXYQUINOXALINE	A	1PFE	0.82
QUI	2-CARBOXYQUINOXALINE	A,B	2DA8	0.82
QUI	2-CARBOXYQUINOXALINE	A,C,E,G	2ADW	0.82
QUI	2-CARBOXYQUINOXALINE	A	1VS2	0.82
QUI	2-CARBOXYQUINOXALINE	A	1XVN	0.82
QUI	2-CARBOXYQUINOXALINE	A,B	185D	0.82
QUI	2-CARBOXYQUINOXALINE	A	1XVK	0.82
QUI	2-CARBOXYQUINOXALINE	A,C	1XVR	0.82
QUI	2-CARBOXYQUINOXALINE	A,B	3GO3	0.82
N12	N-[(1R)-2-[(1-{[({6-[AMINO(IMINO)METHYL]PYRIDIN-3-YL}METHYL)AMINO]CARBONYL}CYCLOPENTYL)AMINO]-1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]GLYCINE	H,P	2ANK	0.72
C48	N1-(1-DIMETHYLCARBAMOYL-2-PHENYL-ETHYL)-2-OXO-N4-(2-PYRIDIN-2-YL-ETHYL)-SUCCINAMIDE	A	1CVZ	0.7
BO2	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE	2,H,K,N,V,Y	2F16	0.75
Q2Y	4-OXO-3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID	A	1RWM	0.72
LIQ	N-{(1S)-2-({(1S,2R)-1-(3,5-DIFLUOROBENZYL)-3-[(3-ETHYLBENZYL)AMINO]-2-HYDROXYPROPYL}AMINO)-2-OXO-1-[(PENTYLSULFONYL)METHYL]ETHYL}NICOTINAMIDE	A	2HM1	0.73
M2C	(2S)-2-AMINO-4-(METHYLSULFANYL)-1-PYRIDIN-2-YLBUTANE-1,1-DIOL	A	1QXY	0.73
PYA	3-(1,10-PHENANTHROL-2-YL)-L-ALANINE	A	1HCW	0.74
NA9	N-(CARBOXYMETHYL)-3-CYCLOHEXYL-D-ALANYL-N-({6-[AMINO(IMINO)METHYL]PYRIDIN-3-YL}METHYL)-N~2~-METHYL-L-ALANINAMIDE	H,P	2A2X	0.73
QYT	(5E)-5-(QUINOXALIN-6-YLMETHYLENE)-1,3-THIAZOLIDINE-2,4-DIONE	A	2A5U	0.74
4QB	3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID	A	1RWN	0.72